ArticleCancer management and research2015

Pharmacokinetics, safety, and efficacy of APF530 (extended-release granisetron) in patients receiving moderately or highly emetogenic chemotherapy: results of two Phase II trials.

Nashat Gabrail et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.